The role of procalcitonin in the follow-up of medullary thyroid cancer

The role of procalcitonin in the follow-up of medullary thyroid cancer

Objective: Calcitonin (Ct) represents the most important biochemical marker of medullary thyroid cancer (MTC), but has certain limits. We analyzed the performance of procalcitonin (ProCt) in follow-up MTC patients. Methods: In this monocentric and retrospective study, we consecutively obtained Pro...

Full description

Bibliographic Details
Main Authors:	Jacopo Manso, Teresa Benvenuti, Ilaria Piva, Maurizio Iacobone, Alberto Mondin, Francesca Torresan, Daniela Basso, Gino Crivellari, Stefania Zovato, Caterina Mian
Format:	Article
Language:	English
Published:	Bioscientifica 2023-01-01
Series:	European Thyroid Journal
Subjects:	procalcitonin calcitonin medullary thyroid carcinoma follow-up
Online Access:	https://etj.bioscientifica.com/view/journals/etj/12/1/ETJ-22-0161.xml

Similar Items

Basal and Calcium-Stimulated Procalcitonin for the Diagnosis of Medullary Thyroid Cancers: Lights and Shadows
by: Simona Censi, et al.
Published: (2021-10-01)

Persistence of Elevated Procalcitonin in a Patient with Coronavirus Disease 2019 Uncovered a Diagnosis of Medullary Thyroid Carcinoma
by: Laura Gianotti, MD, PhD, et al.
Published: (2021-09-01)

Calcitonin negative Medullary Thyroid Carcinoma: a challenging diagnosis or a medical dilemma?
by: Claudio Gambardella, et al.
Published: (2019-05-01)

Serum Biochemical Markers for Medullary Thyroid Carcinoma: An Update
by: Liu S, et al.
Published: (2024-04-01)

Case Report: Medullary Thyroid Cancer Workup Initiated by Unexpectedly High Procalcitonin Level—Endocrine Training Saves Life in the COVID-19 Unit
by: Livia Sira, et al.
Published: (2021-10-01)

Calcitonin receptor expression in medullary thyroid carcinoma
by: Virginia Cappagli, et al.
Published: (2017-09-01)

Oncologic outcomes of calcitonin-negative medullary thyroid carcinoma
by: Wenliang Yue, et al.
Published: (2022-11-01)

Diagnosis and treatment of medullary thyroid carcinoma-an update
by: CHEN Chengkun, GUO Bomin, DENG Xianzhao, WU Bo, FAN Youben
Published: (2022-06-01)

Progress of study on medullary thyroid carcinoma with serum calcitonin-negative and large mass
by: LI Rui, LIU Zhuoran, YAN Jiqi
Published: (2022-06-01)

False positive results using calcitonin as a screening method for medullary thyroid carcinoma
by: Rafael Loch Batista, et al.
Published: (2013-01-01)

Metastatic medullary thyroid carcinoma: A case report
by: Mitra Niafar, et al.
Published: (2011-01-01)

To screen or not to screen for medullary thyroid cancer? This is (yet) the question. An illustrative case.
by: Rosaria Ruggeri, et al.
Published: (2018-12-01)

Breast metastasis from medullary thyroid carcinoma: a report of a case
by: Yoko Omi, et al.
Published: (2021-08-01)

Validation of miRNAs as diagnostic and prognostic biomarkers, and possible therapeutic targets in medullary thyroid cancers
by: Alberto Mondin, et al.
Published: (2023-06-01)

Prognostic Value of Preoperative Serum Calcitonin Levels for Predicting the Recurrence of Medullary Thyroid Carcinoma
by: Hyunju Park, et al.
Published: (2021-10-01)

Serum Calcitonin-Negative Medullary Thyroid Carcinoma: A Case Series of 19 Patients in a Single Center
by: Sun Jung Kim, et al.
Published: (2021-11-01)

Unusual increase in carcinoembryonic antigen despite response to selpercatinib in two patients with medullary thyroid cancer
by: Stéphane Bardet, et al.
Published: (2023-01-01)

Small cell medullary thyroid carcinoma: A diagnostic dilemma
by: Anuj Verma, et al.
Published: (2017-01-01)

Analysis of some prognostic factors significance for medullary thyroid cancer metastasis
by: V.O. Palamarchuk, et al.
Published: (2022-03-01)

Changes of biochemical factors and the effect on recurrence of medullary thyroid carcinoma after surgery
by: Fengli Guo, et al.
Published: (2024-04-01)

Clinicopathological characteristics and prognostic analysis of medullary thyroid carcinoma in children and adolescents
by: LIU Wei , WANG Xiaojiang , ZHANG Jing , ZHU Weifeng , PENG Fengying , WANG Jianchao , XIAO Weijin , HU Dan
Published: (2021-11-01)

Update on Calcitonin Screening for Medullary Thyroid Carcinoma and the Results of a Retrospective Analysis of 12,984 Patients with Thyroid Nodules
by: Martina Broecker-Preuss, et al.
Published: (2023-04-01)

A rare case of medullary carcinoma
by: O.Z. Lishchuk, et al.
Published: (2023-10-01)

Cytodiagnosis of medullary carcinoma thyroid- role of FNAC and serum calcitonin- A case report
by: Majed B Momin, et al.
Published: (2018-01-01)

IGF-1 influences Everolimus activity in medullary thyroid carcinoma
by: Erica eGentilin, et al.
Published: (2015-05-01)

Diagnostic accuracy of routine calcitonin measurement for the detection of medullary thyroid carcinoma in the management of patients with nodular thyroid disease: a meta-analysis
by: Irfan Vardarli, et al.
Published: (2021-04-01)

Unilateral Surgery for Medullary Thyroid Carcinoma: Seeking for Clinical Practice Guidelines
by: Daqi Zhang, et al.
Published: (2022-07-01)

Early calcitonin levels in medullary thyroid carcinoma: Prognostic role in patients without distant metastases at diagnosis
by: Clotilde Sparano, et al.
Published: (2023-02-01)

Diagnosis and treatment of medullary thyroid carcinoma: A case report
by: Xin Nie, et al.
Published: (2023-11-01)

Medullary carcinoma of thyroid: Case report and a review of literature
by: Ratna Priya, et al.
Published: (2016-01-01)

Early postoperative calcitonin-to-preoperative calcitonin ratio as a predictive marker for structural recurrence in sporadic medullary thyroid cancer: A retrospective study
by: Zan Jiao, et al.
Published: (2022-12-01)

Update on Targeted Therapy in Medullary Thyroid Cancer
by: Christian Okafor, et al.
Published: (2021-08-01)

Carcinoembryonic antigen levels correlated with advanced disease in medullary thyroid cancer
by: Sena Turkdogan, et al.
Published: (2018-09-01)

Measuring discrepancies between simple medullary and synchronous medullary/papillary thyroid carcinomas: a comparative cross-sectional study
by: Daqi Zhang, et al.
Published: (2024-01-01)

A Calcitonin-Negative Neuroendocrine Tumor Derived from Follicular Lesions of the Thyroid
by: Ga Young Kim, et al.
Published: (2015-06-01)

An audit of medullary thyroid carcinoma from a tertiary care hospital in northwest India
by: Ananda Mohan Chakraborty, et al.
Published: (2024-01-01)

Plasma levels of calcitonin in medullary thyroid carcinoma patients with and without the RET proto-oncogene mutations in exons 10 and 11
by: Samira Ehyayi, et al.
Published: (2017-09-01)

New Opportunities for Preoperative Diagnosis of Medullary Thyroid Carcinoma
by: Sergei A. Lukyanov, et al.
Published: (2023-05-01)

Medullary thyroid cancer. Returning to the need to determine the preoperative basal calcitonin level in patients with thyroid nodular pathology
by: Elena E. Stanyakina, et al.
Published: (2019-05-01)

Calcitonin‐secreting pancreatic neuroendocrine tumor in a patient with elevated thyroid fine‐needle aspirate calcitonin washout: A case report and review of the literature
by: Darryl Mason, et al.
Published: (2022-01-01)